Literature DB >> 22075449

Treatment of locally advanced pancreatic cancer: the role of radiation therapy.

Kimberly Johung1, Muhammad Wasif Saif, Bryan W Chang.   

Abstract

Pancreatic cancer remains associated with an extremely poor prognosis. Surgical resection can be curative, but the majority of patients present with locally advanced or metastatic disease. Treatment for patients with locally advanced disease is controversial. Therapeutic options include systemic therapy alone, concurrent chemoradiation, or induction chemotherapy followed by chemoradiation. We review the evidence to date regarding the treatment of locally advanced pancreatic cancer (LAPC), as well as evolving strategies including the emerging role of targeted therapies. We propose that if radiation is used for patients with LAPC, it should be delivered with concurrent chemotherapy and following a period of induction chemotherapy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22075449     DOI: 10.1016/j.ijrobp.2011.08.008

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  Intensifying local radiotherapy for pancreatic cancer-who benefits and how do we select them?

Authors:  Sunil Krishnan; Mediha Ahmad
Journal:  J Gastrointest Oncol       Date:  2013-12

2.  The controversial role of chemoradiation for patients with locally advanced pancreatic cancer.

Authors:  Jason E Faris; Jennifer Y Wo
Journal:  Oncologist       Date:  2013-09-10

3.  Dosimetric and clinical toxicity comparison of critical organ preservation with three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and RapidArc for the treatment of locally advanced cancer of the pancreatic head.

Authors:  L Jin; R Wang; S Jiang; J Yue; T Liu; X Dou; K Zhu; R Feng; X Xu; D Chen; Y Yin
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

4.  Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study.

Authors:  Agata I Rembielak; Pooja Jain; Andrew S Jackson; Melanie M Green; Gillian R Santorelli; Gillian A Whitfield; Adrian Crellin; Angel Garcia-Alonso; Ganesh Radhakrishna; James Cullen; M Ben Taylor; Ric Swindell; Catharine M West; Juan Valle; Azeem Saleem; Patricia M Price
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

5.  Distribution of Gemcitabine Is Nearly Homogenous in Two Orthotopic Murine Models of Pancreatic Cancer.

Authors:  Robin M Kramer; James Russell; John L Humm
Journal:  Cancer Biother Radiopharm       Date:  2015-07-23       Impact factor: 3.632

6.  ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer.

Authors:  T Watanabe; H Ueno; Y Watabe; N Hiraoka; C Morizane; J Itami; T Okusaka; N Miura; T Kakizaki; T Kakuya; M Kamita; A Tsuchida; Y Nagakawa; H Wilber; T Yamada; K Honda
Journal:  Br J Cancer       Date:  2015-01-20       Impact factor: 7.640

7.  The combination therapy of high-intensity focused ultrasound with radiotherapy in locally advanced pancreatic carcinoma.

Authors:  Yu-Jiang Li; Gui-Lin Huang; Xu-Ling Sun; Xin-Chun Zhao; Zhi-Gang Li
Journal:  World J Surg Oncol       Date:  2016-02-29       Impact factor: 2.754

8.  Endoscopic ultrasonography guided transgastric trans-portal system fine needle aspiration for diagnosing pancreatic head and uncinate process malignancy.

Authors:  Min Wang; Shu Huang; Rong Pei; Jie Lin; Xiujiang Yang
Journal:  Ann Transl Med       Date:  2019-12

9.  An in vivo study of the effects on serum glucose, amylase and histopathology of the feline pancreatic tissue treated by focused ultrasound.

Authors:  Ying Mao; Liaoqiong Fang; Liang Ai; Chongyan Li; Zhibiao Wang; Junru Wu; Jin Bai; Faqi Li
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

10.  ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.

Authors:  James M Wilson; Emmanouil Fokas; Susan J Dutton; Neel Patel; Maria A Hawkins; Cynthia Eccles; Kwun-Ye Chu; Lisa Durrant; Aswin G Abraham; Mike Partridge; Martha Woodward; Eric O'Neill; Tim Maughan; W Gillies McKenna; Somnath Mukherjee; Thomas B Brunner
Journal:  Radiother Oncol       Date:  2016-04-23       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.